LTX-315

SynDRA canonical compound SYN1973359 — structure-anchored drug synonym record

Clinical phase	Phase 2
Mechanism of action	anticancer agent

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

KSYK
NSD2
NTM1A
NTMT1
SYK

Drug classes

anticancer agent

Cross-references

PubChem CID: 46200994
ChEMBL: CHEMBL4297628
DrugBank: DB12748

Synonyms

Ruxotemitide
LTX 315
Oncopore
Kkwwkkwdipk-nh2
ruxotemitida
ruxotemitidum
RefChem:154173
KKWWKKW-BETA-PHENYL-FK-NH2
Kkwwkkw-.beta.-phenyl-fk-nh2
C78H106N18O9
RUXOTEMITIDE [INN]
UNII-75FBL12IZ7
LTX 315 [WHO-DD]
SCHEMBL29422938
GLXC-22842
s8199
AKOS032945178
CCG-270681
CS-6979
NCGC00507840-03
BS-15278
DA-65090
HY-19894
D84062
Ruxotemitida

Look up LTX-315 in the interactive SynDRA portal →